Fourth-generation chimeric antigen receptor T-cell therapy is tolerable and efficacious in treatment-resistant rheumatoid arthritis.
作者信息
Li Yujing, Li Sujun, Zhao Xiaojuan, Sheng Jun, Xue Lei, Schett Georg, Shi Ce, Hu Biliang, Wang Xingbing, Chen Zhu
机构信息
Department of Rheumatology and Immunology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
Department of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
出版信息
Cell Res. 2025 Mar;35(3):220-223. doi: 10.1038/s41422-024-01068-2. Epub 2025 Jan 9.
Abstract
摘要
Zotero 插件